Robotic-assisted Locomotor Training on Mobility and Cardiopulmonary Function in Patients Suffering From Spinal Cord Injury
Launched by KOWLOON HOSPITAL, HONG KONG · Nov 20, 2013
Trial Information
Current as of May 28, 2025
Completed
Keywords
ClinConnect Summary
Participants will be recruited from the spinal cord rehabilitation unit of Physiotherapy Department of Kowloon Hospital. Subjects will be allocated into intervention group or control group by using sealed envelope and they will be blinded for their group allocation. All participants will undergo standard physiotherapy program, including mobilization and strengthening exercise of limbs, trunk stabilization training, wheelchair maneuver training and overground walking training. Based on this standard training program twice per week, 60 minutes per session, participants will receive an additio...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • adult patient with age 18 or above
- • suffering from incomplete spinal cord injury with classification B, C or D under the International Standards for Neurological Classification of Spinal Cord Injury (ISNSCI)
- • lesion level above or at T12; acquired the injury not more than 24 months at the time of recruitment
- • traumatic or non-traumatic, non-progressive lesion
- • able to tolerate standing on tilt-table in 90 degrees for more than 30 minutes
- • able to walk with or without orthosis but requires manual assistance in walking.
- Exclusion Criteria:
- • fracture of spine or lower limbs which is not yet stabilized
- • severe osteoporosis or at high risk of pathological fracture
- • symptomatic postural hypotension; cardiac disease which is not recommended for moderate intensity exercise
- • severe muscle spasticity over lower limbs
- • severe lower limbs fixed contractures
- • leg length discrepancy for more than 2 centimeters
- • body weight exceeding 135 kilograms
About Kowloon Hospital, Hong Kong
Kowloon Hospital, located in Hong Kong, is a leading healthcare institution dedicated to providing high-quality medical services and advancing clinical research. As a prominent clinical trial sponsor, Kowloon Hospital focuses on innovative therapeutic approaches and patient-centered care, aiming to enhance treatment outcomes across various medical fields. The hospital's commitment to ethical research practices and collaboration with multidisciplinary teams ensures robust clinical trial methodologies and the integration of the latest scientific advancements. Through its comprehensive research programs, Kowloon Hospital strives to contribute to the global medical community and improve patient health outcomes in Hong Kong and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hong Kong, , China
Patients applied
Trial Officials
Cheung Yu Yeung E, BSc
Principal Investigator
Kowloon Hospital, Hong Kong
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials